About Us
Our Company

Board Of Directors

Our Workplace

Our Partners

…we value life.
Our services are focused on the commitment to providing a better life for all people. Our array of products, how we manufacture them, and how we interact with society – preserve our mantra.
Our Products
Adding value.
We are fully invested in promoting a better life for all people, and this reflects in the way we manufacture and present our affordable products.

Products

Registered Distributors

Pharmaceuticals
Your Health
Fidson Healthcare Plc is dedicated to providing the latest and most accurate information on health conditions, enabling individuals to make informed decisions for their well-being.
We are dedicated to providing the latest and most accurate information on health conditions, enabling individuals to make informed decisions for their well-being.
At Fidson, we value life

Diseases & Conditions

Cancer

Cold and Flu

Diabetes

Eye And Ear Care

Healthy Living

Antibiotics

Brain And Nervous System

Digestive Health

Immune System

Managing Your Health

Evaluating Health Information

Health Literacy

Wellness
Investors
Shareholder Information

Corporate Governance

Financial Reports

Find out the latest information on our financial performance, corporation governance and plans for the future.
News & Media
See what we have been up to

Keep up to date with our news and recent announcements

Products Announcements

Events

Press Releases
Responsibility
Corporate Social Responsibility

Health, Safety, and Environment

Quality Policy

We believe that our business endeavors should have a positive effect on the environment and society as a whole.
Contact

Xylase®dz

September 27, 2022

Active Ingredients: Latanoprost 0.005% + Dorzolamide 0.5%

Indication

Treatment of elevated intraocular pressure in patients with open-angle glaucoma
Pseudo-exfoliative glaucoma when topical beta-blocker monotherapy is not sufficient.

Latest News

IMPROVING EYE CARE IN AFRICA: INTRODUCING ATROPINE 1% EYE DROP FROM FIDSON’S AVENTRA PROVISION

We are excited to introduce the newest member of the...

April 13, 2026

Fidson holds Signing Ceremony to commence Rights Issue for N21billion to Fortify Market Dominance

Fidson Healthcare Plc, Nigeria’s leading pharmaceutical manufacturer, on Friday, December...

December 12, 2025

FIDSON APPOINTS TWO NEW FEMALE INDEPENDENT NON-EXECUTIVE DIRECTORS

Nigeria’s leading pharmaceutical company, Fidson Healthcare Plc announces the appointment...

November 21, 2025

Fidson Signs MOU with Japanese Firm at TICAD9

In a significant move set to transform Africa’s healthcare landscape,...

September 3, 2025

Continue Reading

Xylase®dz

Active Ingredients: Latanoprost 0.005% + Dorzolamide 0.5% Indication Treatment of elevated intraocular pressure in patients with open-angle glaucoma Pseudo-exfoliative glaucoma when topical beta-blocker monotherapy is not sufficient.

September 27, 2022 No Comments

268, Ikorodu Road, Obanikoro P. O. Box 7210, Shomolu, Lagos, Nigeria

To report any adverse reaction to any of our products, please call +234 807 700 8888.

…we value life.

Adding value.

At Fidson, we value life

See what we have been up to

Xylase®dz

Xylase®dz

Latest News

Continue Reading

RELATED POSTS

Xylase®dz